These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 15608651

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.
    Karaca E, Tozluoğlu M, Nussinov R, Haliloğlu T.
    J Mol Biol; 2011 Mar 04; 406(4):620-30. PubMed ID: 21216249
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A stable chemical SUMO1-Ubc9 conjugate specifically binds as a thioester mimic to the RanBP2-E3 ligase complex.
    Sommer S, Ritterhoff T, Melchior F, Mootz HD.
    Chembiochem; 2015 May 26; 16(8):1183-9. PubMed ID: 25917782
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Solution structure of human SUMO-3 C47S and its binding surface for Ubc9.
    Ding H, Xu Y, Chen Q, Dai H, Tang Y, Wu J, Shi Y.
    Biochemistry; 2005 Mar 01; 44(8):2790-9. PubMed ID: 15723523
    [Abstract] [Full Text] [Related]

  • 7. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
    Ritterhoff T, Das H, Hao Y, Sakin V, Flotho A, Werner A, Melchior F.
    Methods Mol Biol; 2016 Mar 01; 1475():41-54. PubMed ID: 27631796
    [Abstract] [Full Text] [Related]

  • 8. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH, Kim S, Yu B, Jaffray E, Song J, Zheng J, Rodriguez MS, Hay RT, Chen Y.
    Biochemistry; 2003 Aug 26; 42(33):9959-69. PubMed ID: 12924945
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2.
    Gareau JR, Reverter D, Lima CD.
    J Biol Chem; 2012 Feb 10; 287(7):4740-51. PubMed ID: 22194619
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.
    Ritterhoff T, Das H, Hofhaus G, Schröder RR, Flotho A, Melchior F.
    Nat Commun; 2016 May 10; 7():11482. PubMed ID: 27160050
    [Abstract] [Full Text] [Related]

  • 15. The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type.
    Pichler A, Knipscheer P, Saitoh H, Sixma TK, Melchior F.
    Nat Struct Mol Biol; 2004 Oct 10; 11(10):984-91. PubMed ID: 15378033
    [Abstract] [Full Text] [Related]

  • 16. Protein interactions in the sumoylation cascade: lessons from X-ray structures.
    Tang Z, Hecker CM, Scheschonka A, Betz H.
    FEBS J; 2008 Jun 10; 275(12):3003-15. PubMed ID: 18492068
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction.
    Cooper HJ, Tatham MH, Jaffray E, Heath JK, Lam TT, Marshall AG, Hay RT.
    Anal Chem; 2005 Oct 01; 77(19):6310-9. PubMed ID: 16194093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.